Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.28 USD | -1.24% | +1.41% | +37.87% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.87% | 6.56B | |
+63.75% | 62.59B | |
-2.31% | 41.18B | |
+44.02% | 40.29B | |
-8.29% | 27.9B | |
+11.79% | 26.21B | |
-21.87% | 19.09B | |
+4.72% | 13.08B | |
+24.95% | 12.26B | |
+28.03% | 12.05B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Needham Adjusts Revolution Medicines' Price Target to $46 From $36, Keeps Buy Rating